Some 60% of virus spread starts with those who have no symptoms. A cough or sneeze in the checkout line at the grocery store may elicit fear of COVID-19, but that maskless person quietly sitting next to you on the subway could pose just as much of a threat, public health experts say. Dr. Helen Chu, infectious disease physician at the University of Washington School of Medicine, was featured.
Multisite Trial Early Data Suggests Remdesivir is Effective (UW Medicine Newsroom, Interview with Helen Chu)
Remdesivir, a non-specific antiviral drug that was originally tested against Ebola, has been shown to be effective against the new coronavirus in a preliminary data analysis, as reported by the National Institutes of Health. The UW School of Medicine was one of the sites in the National Institutes of Health trial. Dr.
Researchers have been studying COVID-19 in homeless communities, specifically in shelters with two or more confirmed cases in the weeks prior to their study. They found that in these shelters with clusters of cases, the proportion of positive tests was higher than in shelters with lower amounts of previously reported cases.
Only 10-20% of people with flu-like symptoms actually have the influenza virus. But a new study in Seattle will offer real time testing of the flu this year promising results in less than 30 minutes.
The study will take place at Harborview Medical Center and six other locations around Seattle. If you've had two flu-like symptoms: body aches, cough, or fever in the last week, you're eligible to participate in the study.
After signing a consent form, UW grad students will swab your nose and test for flu and other stuff.